What does TAKEDA PHARMACEUTICAL CO LTD hold? Q3 2025 13F Holdings & Portfolio

AI Analysis · Q3 2025 · Q3 2025

TAKEDA PHARMACEUTICAL CO LTD filed its latest 13F-HR for Q3 2025. See the latest holdings and position changes below.

Quarter at a glance — Q3 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q3 2025.

#HoldingValueSharesWeight

Ovid Therapeutics, Inc.

$10M7.5M59.8%

Equillium, Inc.

$3M1.8M15.9%

Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics)

$1M1.5M7.6%

Shattuck Labs, Inc.

$1M516K7.5%

Lyell Immunopharma, Inc.

$891,36555K5.4%

American Well Corporation

$478,06178K2.9%

Rani Therapeutics Holdings, Inc.

$101,554203K0.6%

Standard Biotools, Inc.

$21,47017K0.1%

Filing history loading…